Page last updated: 2024-12-07

nopaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nopaline is a non-protein amino acid derivative of arginine and pyruvate. It is produced by certain strains of Agrobacterium, a genus of bacteria known for their ability to transfer genes into plants. Nopaline is synthesized via the action of the nopaline synthase (nos) gene, which is a key component of the Ti plasmid of Agrobacterium. Nopaline is thought to be a source of nitrogen and carbon for Agrobacterium, and its presence is often used as an indicator of Agrobacterium infection in plants. The biosynthesis of nopaline involves the condensation of arginine and pyruvate, catalyzed by the nos enzyme. Nopaline is a key player in the interaction between Agrobacterium and plants. It is involved in the induction of crown gall disease, a plant disease caused by Agrobacterium. Nopaline has also been studied for its potential use as a biofertilizer, due to its ability to stimulate plant growth. Research into nopaline has contributed to our understanding of plant-bacterial interactions, and its role in the development of crown gall disease. Nopaline is also studied in the context of genetic engineering, as it can be used as a selectable marker for Agrobacterium-mediated transformation.'

nopaline: utilized by virulent strains of Agrobacterium; metabolites of crown-gall tumors; isonopaline refers to (R-isomer) of nopaline; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-nopaline : An amino acid opine resulting from the formal reductive condensation of the amino group of L-arginine with the keto group of 2-oxopentanedioic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID108012
CHEBI ID17249
SCHEMBL ID7823698
MeSH IDM0052710

Synonyms (26)

Synonym
n(2)-(d-1,3-dicarboxypropyl)-l-arginine
n-[4-[(aminoiminomethyl)amino]-1-carboxybutyl]-d-glutamic acid(ecl)
CHEBI:17249
(s)-n-(4-((aminoiminomethyl)amino)-1-carboxybutyl)-d-glutamic acid
(2r)-2-{[(1s)-4-carbamimidamido-1-carboxybutyl]amino}pentanedioic acid
n2-(d-1,3-dicarboxypropyl)-l-arginine
nopaline
C01682
n-[(1s)-4-carbamimidamido-1-carboxybutyl]-d-glutamic acid
22350-70-5
d-nopaline
d-glutamic acid, n-[(1s)-4-[(aminoiminomethyl)amino]-1-carboxybutyl]-
isonopaline
qj8ep5f7x8 ,
d-glutamic acid, n-(4-((aminoiminomethyl)amino)-1-carboxybutyl)-, (s)-
unii-qj8ep5f7x8
d-glutamic acid,n-[(1s)-4-[(aminoiminomethyl)amino]-1-carboxybutyl]-
SCHEMBL7823698
(2r)-2-[[(1s)-1-carboxy-4-(diaminomethylideneamino)butyl]amino]pentanedioic acid
DTXSID20945005
Q27102284
2w2 ,
(r)-2-(((s)-1-carboxy-4-guanidinobutyl)amino)pentanedioic acid
d-glutamic acid, n-[4-[(aminoiminomethyl)amino]-1-carboxybutyl]-, (s)-
n-[(1s)-4-[(aminoiminomethyl)amino]-1-carboxybutyl]-d-glutamic acid
(2r)-2-{[(1s)-1-carboxy-4-[(diaminomethylidene)amino]butyl]amino}pentanedioic acid

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (6)

ClassDescription
guanidinesAny organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.
tricarboxylic acidAn oxoacid containing three carboxy groups.
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
amino acid opineAny opine whose structure is based on the condensation of an amino acid with a carbohydrate or a keto-acid.
L-arginine derivativeA proteinogenic amino acid derivative resulting from reaction of L-arginine at the amino group, the carboxy group, or the guanidyl group, or from the replacement of any hydrogen of L-arginine by a heteroatom.
D-glutamic acid derivativeA non-proteinogenic amino acid derivative resulting from the formal reaction of D-glutamic acid at the amino group or either carboxy group, or from the replacement of any hydrogen of D-glutamic acid by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-199044 (42.72)18.7374
1990's35 (33.98)18.2507
2000's12 (11.65)29.6817
2010's11 (10.68)24.3611
2020's1 (0.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.16 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.89%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other104 (98.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]